The Therapeutic Goods Administrations (TGA) warning came after several GLP-1 RA medicines marketed in Australia as Ozempic, Wegovy and Mounjaro, among other products, were linked to 36 cases of the condition
FBS, DMEM, and tissue culture reagents were obtained from Invitrogen (Carlsbad, CA, USA)
What the Evidence Shows and What It Does Not The FDA approval is based on data from the Phase 3 ATTAIN clinical trial program
To help manage these side effects, follow the prescribed dose-escalation schedule exactly it's specifically designed to reduce GI effects
We slow the titration, adjust meal timing and hydration, or consider alternative therapies